[ETCM]

Under the FDA approval of "compassionate use", the patient must have a "life threatening condition". Only patients who are in serious condition should be given HCQ under compassionate use guidelines. This doctor's "any patient with shortness of breath, regardless of age" is quite a stretch on that guidance. Though there are large quantities of HCQ entering the pharmacy system, we do need to be careful about using it on milder cases.

By the end of May, we should have 200 Million tablets and much more on the way as production ramps up. As supplies increase, more liberal use should follow.

[Jane Long]

Okay, see you in May 😊

[Tolerance Sucks Rocks]

That doc’s right. Any patient with shortness of breath could help slam the mostly-filled ICU’s, costing millions of dollars apiece if it is COVID-19 (long stays). It’s preferable to spend a few hundred a person up front doling out the treatment to anybody with a breathing problem, fever and cough, since testing is still just ramping up.